A Survivorship Care Plan and Embedded Navigation Tool

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

This is a parallel group, multisite prospective clinical study. The purpose of this study is to evaluate whether ASCENT enables patients to adhere to the survivorship guidelines and improves coordination of care to address patient needs.

Key facts

Study ID

NCT03424837

Run by

Duke University

People needed

77

Starts

2019-01-11

Expected to finish

2020-11-24

Last updated by the study team

2021-07-29

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed diagnosis of prostate adenocarcinoma
• Age ≥18 years
• Receiving curative intent radiotherapy for prostate cancer (Note: post-operative radiotherapy [i.e., "adjuvant" or "salvage radiotherapy subsequent to prostatectomy] is allowed.)
• Subjects will be enrolled within two weeks prior to and two weeks after the final fraction of radiotherapy.
• Receiving androgen deprivation therapy (ADT) for a duration of ≥3 consecutive months as follows:
• GnRH agonist or antagonist (medical castration), with or without an anti-androgen (i.e., bicalutamide, flutamide, nilutamide, etc.), OR
• Bilateral orchiectomy (surgical castration)
• Technology requirement: candidates must have access to the internet
• Able to understand and willing to sign a written informed consent document.
• Able to speak and understand English, in the opinion of the treating physician.

You may not qualify if…

• Significant concurrent medical or psychiatric condition that would interfere with the patient's ability to abide by the study protocol or cooperate fully with the protocol requirements, including completion of survey and assessment

Where it is running

• H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida, United States
• Emory University & Winship Cancer Institute — Atlanta, Georgia, United States
• Johns Hopkins School of medicine & Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• UNC Lineberger Cancer Center — Chapel Hill, North Carolina, United States
• Duke Cancer Institute — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.